HIV Drug Resistance in Adults Initiating or Reinitiating Antiretroviral Therapy in Uruguay-Results of a Nationally Representative Survey, 2018-2019.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
10 02 2023
Historique:
received: 12 01 2023
revised: 31 01 2023
accepted: 02 02 2023
entrez: 28 2 2023
pubmed: 1 3 2023
medline: 3 3 2023
Statut: epublish

Résumé

The first nationally representative cross-sectional HIV drug resistance (HIVDR) survey was conducted in Uruguay in 2018-2019 among adults diagnosed with HIV and initiating or reinitiating antiretroviral therapy (ART).

Identifiants

pubmed: 36851704
pii: v15020490
doi: 10.3390/v15020490
pmc: PMC9961578
pii:
doi:

Substances chimiques

efavirenz JE6H2O27P8
Ritonavir O3J8G9O825
Anti-Retroviral Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : CIHR
ID : PJT-148621
Pays : Canada

Références

J Int AIDS Soc. 2019 Dec;22(12):e25429
pubmed: 31860167
J Virol Methods. 2008 Nov;153(2):176-81
pubmed: 18706932
J Antimicrob Chemother. 2016 Feb;71(2):362-6
pubmed: 26546669
J Antimicrob Chemother. 2020 Jul 1;75(7):1932-1942
pubmed: 32303063
J Med Virol. 2022 Oct;94(10):5061-5065
pubmed: 35701340
J Infect Dis. 2017 May 1;215(9):1362-1365
pubmed: 28329236
J Antimicrob Chemother. 2017 Feb;72(2):504-510
pubmed: 27789684
Mol Biol Evol. 2013 Dec;30(12):2725-9
pubmed: 24132122
J Clin Microbiol. 2012 Jun;50(6):1936-42
pubmed: 22403431
PLoS One. 2019 Sep 3;14(9):e0221879
pubmed: 31479466
Infect Genet Evol. 2013 Oct;19:337-48
pubmed: 23660484
J Antimicrob Chemother. 2017 Nov 01;72(11):3149-3158
pubmed: 28961972
PLoS One. 2009;4(3):e4724
pubmed: 19266092
Lancet Infect Dis. 2018 Mar;18(3):346-355
pubmed: 29198909
J Antimicrob Chemother. 2020 Jan 1;75(1):170-182
pubmed: 31617907
J Antimicrob Chemother. 2019 Apr 1;74(4):1044-1055
pubmed: 30597094
Mol Biol Evol. 2018 Jul 1;35(7):1812-1819
pubmed: 29401317
Clin Infect Dis. 2006 Jun 1;42(11):1608-18
pubmed: 16652319
Nucleic Acids Res. 2003 Jan 1;31(1):298-303
pubmed: 12520007

Auteurs

Rosa Flieller (R)

Unidad de Virología, Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11600, Uruguay.

Susana Cabrera (S)

Programa de ITS-VIH/SIDA, Ministerio de Salud Pública, Montevideo 11200, Uruguay.
Facultad de Medicina, Universidad de la República, Montevideo 11800, Uruguay.

Dora Ruchansky (D)

Unidad de Virología, Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11600, Uruguay.

Amalia Girón-Callejas (A)

Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.

María Brasesco (M)

Unidad de Virología, Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11600, Uruguay.

Daniel Pérez (D)

Programa de ITS-VIH/SIDA, Ministerio de Salud Pública, Montevideo 11200, Uruguay.

Héctor Chiparelli (H)

Unidad de Virología, Departamento de Laboratorios de Salud Pública, Ministerio de Salud Pública, Montevideo 11600, Uruguay.

Claudia García-Morales (C)

Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.

Daniela Tapia-Trejo (D)

Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.

Jessica Monreal-Flores (J)

Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.

Giovanni Ravasi (G)

Pan American Health Organization, Washington, DC 20037, USA.

Michael R Jordan (MR)

Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA 02111, USA.
Levy Center for Integrated Management of Antimicrobial Resistance, Tufts University School of Medicine, Boston, MA 02111, USA.

Santiago Ávila-Ríos (S)

Centre for Research in Infectious Diseases, National Institute of Respiratory Diseases, Mexico City 14080, Mexico.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH